Contents
Current Drug Targets, Volume 16 - Number 7
Is there a Role for Bevacizumab in Non-Glial Tumors?
, 16(7): 684 - 688Elisa Trevisan, Luca Bertero, Michela Magistrello, Roberta Ruda and Riccardo Soffietti
DOI: 10.2174/1389450116666150325230810
Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation
, 16(7): 700 - 710Erin E. Witalison, Paul R. Thompson and Lorne J. Hofseth
DOI: 10.2174/1389450116666150202160954
Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
, 16(7): 711 - 734Imran Ali, Mohammad Nadeem Lone, Zeid A. Al-Othman, Abdulrahman Al-Warthan and Mohd. Marsin Sanagi
DOI: 10.2174/1389450116666150309115922
Selective Modulators of α5-Containing GABAA Receptors and their Therapeutic Significance
, 16(7): 735 - 746Ming Shiuan Soh and Joseph W. Lynch
DOI: 10.2174/1389450116666150309120235
Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions
, 16(7): 747 - 756Francesca Scicchitano, Andrew Constanti, Rita Citraro, Giovambattista De Sarro and Emilio Russo
DOI: 10.2174/1389450116666150330114850
Steps and Routes of HCV Infection: The Great Promise of New Anti-Viral Targets
, 16(7): 757 - 770Annalisa Crema, Antonio Ponzetto, Massimo Clementi and Guido Carloni
DOI: 10.2174/1389450116666150213111603
Webmaster Contact: info@benthamscience.org